pharmaceutical

November 1, 2017
ceo update

PHI Group Update from CEO Henry Fahman November 1, 2017

Dear Valued Shareholders, Over the last year, we have made a number of announcements regarding acquisitions, joint ventures and business cooperation and have also created subsidiary companies to manage specific projects. I understand that our shareholders are anxious to see […]
August 29, 2017
PHI Group Update

PHI Group Update from CEO Henry Fahman August 29, 2017

Dear Valued Shareholders, Our primary strategy is acquire target companies in attractive industries with big, growing markets and use them as platforms for further consolidation to create long-term value for our shareholders.  We also invest in special situations that potentially […]
August 28, 2017
healthcare - pharmaceutical

PHI Group Forms Subsidiary, Signs LOI to Acquire European Pharmaceutical and Medical Device Distribution Company

Creating Platform for Distribution of Organic Medicines by Tho Xuan Duong JSC, a 400-year Old Vietnamese Company recognized by Guinness World Records, and patented Low Level Laser Light Therapy Systems to European Markets PHI Group, Inc., (OTCQB: PHIL), a company […]